Ads
related to: novartis ag stock
Search results
Novartis AG's (VTX:NOVN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its...
Simply Wall St. via Yahoo Finance· 1 year agoNovartis (VTX:NOVN) has had a great run on the share market with its stock up by a significant 5.6%...
Investors Heavily Search Novartis AG (NVS): Here is What You Need to Know
Zacks via Yahoo Finance· 1 month agoZacks.com users have recently been watching Novartis (NVS) quite a bit. Thus, it is worth knowing...
Novartis (NVS) to Report Q1 Earnings: What to Expect?
Zacks via Yahoo Finance· 3 weeks agoNovartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2024 results on Apr 23....
Novartis AG (VTX:NOVN) is a favorite amongst institutional investors who own 51%
Simply Wall St. via Yahoo Finance· 8 months agoKey Insights Institutions' substantial holdings in Novartis implies that they have significant...
Novartis AG (VTX:NOVN) most popular amongst individual investors who own 54% of the shares,...
Simply Wall St. via Yahoo Finance· 2 months agoKey Insights Novartis' significant individual investors ownership suggests that the key decisions...
Novartis (NVS) Q2 Earnings & Revenues Top, Guidance Raised
Zacks via Yahoo Finance· 10 months agoSwiss pharma giant Novartis AG NVS reported strong second-quarter 2023 results and shares are...
Novartis (NVS) Q4 Earnings Top, Revenues Miss Estimates
Zacks via Yahoo Finance· 1 year agoNovartis (NVS) reports mixed fourth-quarter results, with key brands maintaining momentum but...
Novartis (NVS) Announces Positive Data on Oncology Drug
Zacks via Yahoo Finance· 2 years agoNovartis' (NVS) anti-PD-1 monoclonal antibody, tislelizumab, significantly extends median overall...
Novartis (VTX:NOVN) Is Paying Out A Larger Dividend Than Last Year
Simply Wall St. via Yahoo Finance· 1 year agoNovartis AG's (VTX:NOVN) dividend will be increasing from last year's payment of the same period to...
Novartis (NVS) Spins off Sandoz, Reiterates Annual Outlook
Zacks via Yahoo Finance· 7 months agoNovartis NVS completed the spin-off of its generic and biosimilar unit, Sandoz, following which...
